GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Net Income From Continuing Operations

IMGT (XKRX:456570) Net Income From Continuing Operations : ₩4,082.37 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is IMGT Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. IMGT's net income from continuing operations for the six months ended in Dec. 2023 was ₩4,082.37 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was ₩4,082.37 Mil.

IMGT Net Income From Continuing Operations Historical Data

The historical data trend for IMGT's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMGT Net Income From Continuing Operations Chart

IMGT Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
-6,622.87 -16,912.67 731.32 4,082.37

IMGT Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations -6,622.87 -16,912.67 731.32 4,082.37

IMGT Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 was ₩4,082.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMGT (XKRX:456570) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IMGT Corp Ltd (XKRX:456570) » Definitions » Net Income From Continuing Operations
Comparable Companies
XKRX:036480 XKRX:208340 XKRX:115180 XKRX:344860 XKRX:383930 XKRX:298060 XKRX:065650 XKRX:299660 XKRX:179530 XKRX:142760 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
172 Dolma-ro,, 408, Healthcare Innovation Park, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13605
Website
http://www.imgt.co.kr
IMGT Corp Ltd develops a focused ultrasound-based drug delivery platform for intractable diseases. It is developing nanomedicines and focused ultrasound medical devices that respond to focused ultrasound. The firm has two pipeline products IMD20 and IMP101. IMD20 is a FUS device developed for chronic pain as a product with reduced size and output from IMD10 developed for cancer treatment. IMP101 is a nanoparticle used for hepatocarcinoma embolization.

IMGT (XKRX:456570) Headlines

No Headlines